The benefits of near-patient, point-of-care tests have not been fully examined. We have assessed the clinical, organizational, and economic outcomes of implementing a near-patient test for C-reactive protein (CRP) in general practice. Methods: In a randomized crossover trial during intervention periods, general practitioners (GPs) were allowed to measure CRP within 3 min, using NycoCard
should be available before the decision to introduce the test is made (16, 17 ) .
The aim of this study was to assess the clinical, organizational, and economic consequences of introducing a near-patient test for CRP measurements in general practice, with special focus on the clinical use of the test, the additional use of ESR, prescription of antibiotics, and utilization of the hospital laboratory service.
Materials and Methods
The catchment area of the hospital laboratory at the Vejle County Central Hospital (Vejle Hospital) covers 136 000 inhabitants and 41 general practice clinics (90 GPs), of which all were invited to participate in this study; 29 clinics (70.1%) accepted [a total of 64 GPs (71.1%)].
intervention
The clinics were randomized into two groups. One group was given access to a near-patient test for CRP (NycoCard CRP Whole Blood; Nycomed Pharma) in the office (intervention), whereas the other group had to order CRP as usual, mailing a blood sample to the laboratory (control).
After a period of 3 months, the two groups interchanged their status (crossover). The first period of intervention and control was 3 months (April-June 1996), and the second period was 4 months (July-October 1996). All clinics received an introductory visit with a demonstration by the manufacturer before their intervention period. No clinical guidelines for the use of CRP were distributed to the clinics.
inclusion of patients
The GPs filled out a registration card for each patient when a CRP was measured in the office or requested at the laboratory. The date for the consultation, the tentative diagnosis, and the CRP value were registered together with the patient's personal registration number.
the danish health service system and the laboratory information system All inhabitants in Denmark have a personal registration number, and it is therefore possible to collect information about any person from independent registries (18 ) . Of the population, 97% are registered at their GPs (19 ) . The GPs (20 ) . The inclusion rates were assessed for each clinic in intervention and control periods. If a clinic had an inclusion rate Ͻ75% in either period, all patients from that clinic were excluded from the study. The clinic itself was not excluded because all outcome measurements at the clinic level were based on data from the Health Service System and the Laboratory Information System, and therefore were independent of the registration of included patients.
ethics
The study was approved by the Danish Data Protection Agency, and the local scientific ethics committee was informed about the study.
Results
It was possible to evaluate data in this study, both at the level of included patients and at the overall level of participating general practice clinics. Results at the level of included patients were suitable to describe the categories of patients having their CRP measured and to evaluate prescription of antibiotics at patient level. Results at the level of included patients are presented in Tables 1-4 . Results at the level of general practice clinics were suitable for organizational and economic evaluation, and these results are presented in Tables 5 and 6 . 
results at the level of included patients
During the study period, 2915 patients were registered at their GPs: 1560 (53.3%) during intervention periods and 1355 (46.5%) during control periods. During the intervention periods, all 29 clinics had an inclusion rate near 100%; however, during the control periods, 13 clinics had an inclusion rate Ͻ75% (range, 6 -67%). All 1041 patients registered by these clinics were excluded. Of the remaining 1874 patients, 21 were excluded because of incomplete registration of personal registration numbers, leaving 919 patients included in the intervention periods and 934 patients included in the control periods.
Sex and age characteristics. The mean age of the included patients was 53.7 years [95% confidence interval (CI), 52.8 -54.6%], and 60.2% (95% CI, 58.0 -62.4%) of the patients were women.
Reasons for measuring CRP and disease characteristics.
The disease characteristics for the included patients are given in Table 1 . During intervention periods, the use of CRP was significantly higher for "diagnosis of new diseases" and "infectious diseases". For patients with sinusitis, the use of CRP during intervention periods was threefold higher than during the control periods, whereas changes for other specified infectious diseases are insignificant. There was a significant decrease in follow-up testing during intervention periods. The decrease in follow-up testing was seen mainly in the group of patients without infections, with a decrease from 18.1% during control Table 2 . The use of ESR was significantly (11%) lower during intervention periods, and the decrease was significant both for patients with CRP values within the health-related reference interval and for patients with high values. For patients with CRP values Յ10 mg/L, the decrease was 9.1% (P ϭ 0.002); for patients with CRP values between 10 and 25 mg/L, the decrease was 12% (P ϭ 0.043); and for patients with CRP values Ն25 mg/L, the decrease was 12.6% (P ϭ 0.014). The use of other supplementary tests remained unchanged. The use of follow-up telephone consultations was also lower during intervention periods, whereas the number of daytime and out-of-hours consultations was unchanged. During control periods, 140 patients (15.0%) had a blood sample forwarded for a CRP measurement only, but the total number of blood samples forwarded to the laboratory declined significantly, from 100% to 60.2%, during intervention periods, which is a reduction of nearly 40%. This reflects a reduction in the number of patient samples forwarded containing a request for other analyses in addition to a CRP measurement. The mean number of requests for additional laboratory tests for each forwarded blood sample was 4.8 tests in intervention periods and 5.5 tests in control periods (i.e., CRP exclusive). In both periods, creatinine, alanine aminotransferase, alkaline phosphatase, WBC, and potassium were the most frequently requested additional tests.
Prescription of antibiotics.
In Table 3 , the prescription of antibiotics is compared for different CRP concentrations.
Patients with infection as the tentative diagnosis and with unspecific diagnoses such as fever, cough, or dyspnea are included. Patients in a follow-up course and with appendicitis were excluded. Antibiotics were prescribed for approximately one-third of all patients with a sign of infection during both intervention and control periods. During both periods, the frequency of prescription increases with an increased magnitude of CRP values (test for trend; P Ͻ0.0001). During both periods, 20% of the patients with a health-related CRP value received an antibiotic prescription. These patients had the same distribution of infectious diagnoses as described in Table 1 . There were no differences between types of antibiotics prescribed during intervention and control periods. In both periods, narrow spectrum penicillin was the most frequently used antibiotic (45%), followed by macrolides (22%), broad spectrum penicillins (20%), quinolones (8%), and sulfa drugs (3%).
Patient delays for collecting antibiotics.
By comparing the date that CRP was measured in each patient with the date that the prescribed antibiotic was dispensed by a pharmacy, a delay for collecting antibiotics can be estimated for each patient (Table 4) . Patients with a CRP value Ͼ50 mg/L had a significantly lower delay in collecting their (20 ) .
antibiotics during intervention periods than during control periods.
results at the level of general practice clinics
Intervention effects. Quick access to CRP measurements led to a reduction of the overall use of ESR by GPs of 8%, whereas their use of other tests was unchanged. The number of CRP tests forwarded to the laboratory was reduced by 65%, and the overall number of blood samples forwarded by GPs was reduced by 6% (Table 5) .
Economic evaluation. The cost-effectiveness for CRP as a near-patient test was calculated (Table 6 ) on the basis of intervention effects (Table 5 ). Implementation of CRP in general practice gave a rise in costs for the Health Service System, but also considerable savings for the laboratories, yielding a total savings of $111 160 per year for a Danish county with 340 000 inhabitants.
Selection bias. The 29 clinics participating in the study were compared with the 12 clinics in the catchment area that declined participation. There were no significant differences for the number of requests for CRP from the laboratory, the use of ESR, the prescription of antibiotics, and the number and ages of the GPs affiliated with the clinics. The same parameters were compared for the 16 clinics with an inclusion rate Ͼ75% and the 13 clinics with a low inclusion rate, and no significant differences were found.
Discussion
We have, under controlled and randomized conditions, given GPs access to quick CRP measurements and have used independent administrative registries to monitor changes in their behavior. This method is in contrast with previous published studies where GPs were asked if a CRP value had influenced their prescription of antibiotics or would have given them better clinical information compared with ESR (12, 13 ) .
study validity
Some clinics had a low inclusion rate in the control period. This probably reflects difficulties in remembering to include patients in a routine situation. To ensure a high internal validity, we excluded all patients from clinics with a low inclusion rate. In the test for selection bias, participating clinics were found representative for all clinics in the catchment area.
esr Some results in this study were found significant at the level of general practices as well as at the level of included patients. At the level of included patients, the use of ESR decreases from 46.3% for control patients to 35.3% for intervention patients (Table 2 ). If we look at the total use of ESR by GPs and not only at ESR used for the patients included in this study, the decrease remains significant, at a total of 8% (Table 5 ). This decrease was achieved after only 3 to 4 months of intervention, and the decrease will Table 6 . Cost-effectiveness of implementing CRP as a near-patient test in general practice in the county of Vejle, Denmark, a based on effects of intervention reported in Table 5 . a On January 1, 1996, the county of Vejle had 339 818 inhabitants. b Currency rate: $1.00 US is 6.50 Dkr. c Results normalized as cost per month per 1000 inhabitants. d Fee to GP for measuring an ESR. e Fee to GP for mailing a blood sample to the hospital laboratory. f Utensils and reagents cost $3.10 for each test, and the GP's fee is supposed to be $3.10 as for an ESR. g Receiving a mailed blood sample costs $7.70, which includes unpacking, registration of patients' data in the Laboratory Information System, securing of patients' personal registration number, storage, and reporting of test result to the requesting clinicians.
h Costs for specified blood tests are variable depending on requirements for manpower, utensils, and reagents. The five blood tests ordered most frequently as additional tests with a requested CRP are all inexpensive and cost from $1.50 to $3.00. A cost of $1.50 is used. i Cost for measuring a CRP at laboratory is $3.85.
probably continue over a period of 4 to 5 years, as has been seen for clinical hospital departments introduced to CRP (21 ) .
blood samples mailed to the laboratory
The number of blood samples forwarded from general practices to the laboratory decreased significantly both at the level of included patients and at the level of GPs. In a previous study, we found that CRP is requested in 34% of all blood samples mailed from general practices (10 ) . In that study, it was not possible to detect whether CRP was requested as an additional test to other primarily ordered tests or whether CRP was actually the blood test necessitating the blood sample. The marked decrease in the number of forwarded blood samples found in this study indicates that CRP actually is a blood test that provokes a blood sample in general practice.
prescription of antibiotics
Surprisingly, we found no major changes in the prescription of antibiotics by GPs (Table 3) . From previous published studies, it could be hypothesized that the overall use of antibiotics would remain unaffected on the basis of more appropriate use of antibiotics, which means a decrease in prescriptions of antibiotics to patients with low CRP values and an increase in the number of prescriptions to patients with high CRP values. In this study, we found that exactly the same number of patients were prescribed an antibiotic at a certain magnitude of CRP values, regardless of whether the test results were given within minutes or days (Table 3) . This observation together with a same-day dispense rate of 70% for both periods (Table 4) illustrates that the effect of the clinical use of the test seems to be uniform for both intervention and control periods. In control periods, antibiotics were prescribed and dispensed before the GP knew the CRP value. The test result, therefore, was not included in the diagnostic process, but perhaps was used as a kind of quality assurance for the clinical decision. It appeared that this pattern of application was copied during the intervention periods, although the test result should have been used as a part of the clinical decision-making process. The group of patients with CRP values within the health-related reference interval but having an antibiotic prescribed had exactly the same distribution of infectious diseases as seen for the whole study population (Table 1) . This means that tentative diagnoses such as pneumonia, sore throat, and sinusitis were dominant and accounted for Ͼ60% of suspected infectious diseases (Table 1) . In general practice, the diagnostic value of CRP of these three diseases is well documented (5, 6, 8 ) . For suspected bacterial pneumonia, the negative predictive value of a CRP value Ͻ50 mg/L is 95%, which means that only 1 of 20 patients will have bacterial pneumonia and a CRP value Ͻ50 mg/L simultaneously (5 ). The predictive value of a CRP value Ͻ10 mg/L would be even higher; however, 20% of patients with health-related CRP values had an antibiotic prescribed. The focus of this study was to investigate changes in the behavior of GPs who have CRP as a near-patient test, not to assess the ability of CRP to distinguish between bacterial and viral infection; therefore, we did not analyze culture data on every patient suspected for an infectious disease. The available literature supports the ability of CRP, although it is an nonspecific marker of infectious disease, to distinguish between bacterial and viral diseases (5-13 ). If we accept this ability to distinguish between diseases, we should have seen a decrease in the prescription of antibiotics to patients with low CRP values during the intervention periods and an increase in the prescription of antibiotics to patients with high CRP values, but this was not seen. Therefore, it seems reasonable to assume that implementation of clinical guidelines for the use of CRP in general practice could give a more appropriate use of antibiotics.
For a single subgroup of patients, a quick CRP result had an effect. Patients tentatively diagnosed clinically as having an infectious disease and with CRP values Ͼ50 mg/L collected their antibiotics sooner from pharmacies when the CRP measurement was made in the clinics (Table 4 ). This suggests that the GPs encouraged their patients to collect their antibiotics the same day, because a high CRP value indicates not only a bacterial infection, but also the severity of the infection (4 ).
telephone consultations
At the level of included patients, a significant decrease in the number of telephone consultations during the follow-up periods during intervention was seen, probably reflecting that patients had received the test result at the primary consultation and that their case was then closed. It was not possible for us to evaluate this result at the level of GPs because we only had permission to receive data for follow-up consultations for included patients.
reasons for measuring crp
Regarding the reasons for CRP measurements, only small differences between the study periods were noticeable. For both periods, a major part of the tests was used for diagnosing a new disease; however, during intervention periods this use was significantly more frequent. This result reflects that the GPs found having the test result of the CRP test while the patient was still in the clinic more useful for diagnostic purposes. A decrease in the frequency of using CRP for follow-up purposes was revealed. CRP is known to be very useful for monitoring the treatment course of infectious patients, by using the patients as their own references (4 ). One could consider that a decrease in follow-up testing could give rise to several recurrences and, therefore, higher costs. We found that the decrease in follow-up testing was seen mainly for the group of patients with noninfectious disease, which typically means patients with chronic inflammatory diseases.
